中文产业新闻精选评分70Chinese source
阿斯利康终止 PD-1/CTLA-4 双抗 Volrustomig 三期 eVOLVE-Lung02 试验
阿斯利康：PD-1/CTLA-4双抗III期失败
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
阿斯利康：PD-1/CTLA-4双抗III期失败
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.